Dividend Seeker.
Fund holdings lookup
Request failed

As of the latest SEC filings, NeuroSense Therapeutics Ltd. (NRSN) is held by 2 institutional funds. The largest fund shareholder is Fidelity Nasdaq Composite Index Fund (FNCMX), holding an estimated $14,424.24 in market value, representing a significant portion of its portfolio.

Funds holding NeuroSense Therapeutics Ltd. (NRSN)

Source: SEC Form N-PORT institutional portfolio disclosures

Ticker:
NRSN
CIK:
0001875091
2 results
Fund Type Manager Weight Market Value Shares
Report Date
Filing Date
FNCMX
Fidelity Nasdaq Composite Index Fund
 MF Fidelity 0.00% $14,424.24 15,870 Feb 28, 2026 Apr 24, 2026
BXMYX
Blackstone Alternative Multi-Strategy Fund
 MF Independent / Boutique 0.00% -$226.52 -300 Mar 31, 2026 May 27, 2026
Advertisement (320x50)